Science Explorer Back to mapMap
Discussion
Researcher · Fuji Chemical Industries (Japan) · Japan

Tadanori Morikawa

Tadanori Morikawa publishes mostly in Molecular Biology, Organic Chemistry and Oncology, on topics such as Peptidase Inhibition and Analysis, Chemical Synthesis and Analysis and Protease and Inhibitor Mechanisms.

OpenAlex
World rank
#6,089,962
of 7,710,434 ranked researchers
Rank in Japan
#229,533
of 383,136
Works
57
Citations
788
Citations per work
13.8
h-index
14
i10-index 19Top 55% in Molecular Biology
Tadanori Morikawa

What does Tadanori Morikawa research?

Tadanori Morikawa's work is mostly in Biochemistry, Genetics and Molecular Biology (27%), Chemistry (20%), Medicine (13%).

Everything else: 20 works · 34.5% of their workLife Sciences: 19 works · 33.4% of their workBiochemistry, Genetics and Molecular Biology: 15 works · 27.1% of their workMolecular Biology: 12 works · 20.8% of their workCancer Research: 4 works · 6.3% of their workNeuroscience: 4 works · 6.3% of their workCellular and Molecular Neuroscience: 4 works · 6.3% of their workPhysical Sciences: 11 works · 19.5% of their workChemistry: 11 works · 19.5% of their workOrganic Chemistry: 11 works · 19.5% of their workHealth Sciences: 7 works · 12.6% of their workMedicine: 7 works · 12.6% of their workOncology: 6 works · 10.1% of their workHematology: 1 works · 2.5% of their workTHEIR WORKTadanori Morikawa57works
Life Sciences33%Physical Sciences20%Health Sciences13%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else2034.5%
    1. Biochemistry, Genetics and Molecular Biology1527.1%
    2. Neuroscience46.3%
    1. Chemistry1119.5%
    1. Medicine712.6%
  1. 1Molecular Biology21% of their works
  2. 2Organic Chemistry20% of their works
  3. 3Oncology10% of their works
  4. 4Cancer Research6% of their works
  5. 5Cellular and Molecular Neuroscience6% of their works
  6. 6Hematology2% of their works

Research topics

Which keywords describe Tadanori Morikawa's research?

The keywords of their largest research topics: Angiogenesis, Drug Discovery, Cell Signaling, Fibroblast Activation Protein, Tumor Microenvironment, Foldamers, Peptide Synthesis and Matrix Metalloproteinases.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Angiogenesis242 topics
  2. Drug Discovery223 topics
  3. Cell Signaling152 topics
  4. Fibroblast Activation Protein141 topic
  5. Tumor Microenvironment141 topic
  6. Foldamers131 topic
  7. Peptide Synthesis131 topic
  8. Matrix Metalloproteinases101 topic
  9. Neuropeptides101 topic
  10. Receptors101 topic
  11. Tissue Inhibitors of Metalloproteinases101 topic
  12. Crystal Structure51 topic
  13. G-Protein-Coupled Receptors51 topic
  14. Glycosidase Inhibitors51 topic
  15. Oligosaccharide Synthesis51 topic
  16. Antioxidant Activity41 topic
  17. Bioactive Peptides41 topic
  18. Click Chemistry41 topic
  19. Copper-Catalyzed Cycloaddition41 topic

Where does Tadanori Morikawa work?

Tadanori Morikawa's main affiliation in the publication record is Fuji Chemical Industries (Japan), Japan.

How many publications and citations does Tadanori Morikawa have?

OpenAlex counts 57 works and 788 citations for Tadanori Morikawa, an h-index of 14, ranking #6,089,962 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Tadanori Morikawa. Posts are plain text and can be reported.